Federica Blua

University of Turin

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Collaborators (9)

Konstantin Chegaev

University of Turin

ITALY

View details

Dr. Federica Sodano

Assistant Professor

University of Naples Federico II

ITALY

View details

Justin MacDonald

Professor

University of Calgary

CANADA

View details

Serena MARCHIO'

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

francesca spyrakis

Associate Professor

University of Turin

ITALY

View details

Massimo Bertinaria

University of Turin

ITALY

View details

Federica Maione

Candiolo Cancer Institute

ITALY

View details

Loretta Lazzarato

Professore associato

Università degli Studi di Torino

ITALY

View details

DANIELE ODDO

Università degli Studi di Torino

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Federica Blua

Research Interests

Explore related searches

Contact this professor

Articles (8)

Solid Lipid Nanoparticles by Coacervation from Natural Soaps: Preliminary Studies for Oral Delivery of an Insulin Analogue

Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma

Exploring flavylium-based SWIR emitters: Design, synthesis and optical characterization of dyes derivatized with polar moieties

Novel NLRP3 inhibitor INF195: Low doses provide effective protection against myocardial ischemia/reperfusion injury

Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage

Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation

Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF<sup>V600E</sup> Protein

Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor

Collaborators (9)

Konstantin Chegaev

Dr. Federica Sodano

Justin MacDonald

Serena MARCHIO'

francesca spyrakis

Massimo Bertinaria

Federica Maione

Loretta Lazzarato

DANIELE ODDO

Make your next move.